PrimaryEndpoint.com providers drug clinical development consultation services
Endpoint
Endpoint is a drug development and consulting firm. It advises and assists its clients in developing medicines and drugs by helping them design and successfully implement the clinical trial of the drug. Endpoint also assists its clients in evaluating the clinical and pre-clinical data of the drug. It helps cooperation between companies and coordinate activities between them.
Services
Evaluate the medical and commercial potential of compounds; Formulate comprehensive clinical development plans; Position products for optimal marketing; Interact with regulatory agencies to gain endorsement of the clinical trial program
Design clinical trials; Assure that clinical studies will meet the requirements of regulatory agencies; Provide strategic review of draft protocols
Review and interpret pre-clinical and clinical data; Evaluate opportunities for potential investors in early-stage products or companies
Suggest partnering strategies for emerging companies; Evaluate and help negotiate in- and out-licensing opportunities; Coordinate activities between companies
Produce authoritative overviews of medical conditions and their current pharmacotherapy; Educate company staff in various aspects of strategic drug development; Assemble and/or chair expert advisory panels
Language
English
People
Contact
Email: 
Additional Information
- Biomedical
- Biotech
- Biotech Due Diligence
- Biotechnology
- Biotechnology Consulting
- Biotechnology Evaluation
- Biotechnology And Pharmaceuticals
- Business
- Cpmp
- Clinical Trial
- Clinical Trial Design
- Clinical Trials
- Company
- Consulting
- Drug Development Consulting
- Drug Studies
- Due Diligence
- Due Diligence Consulting
- Emea
- Endpoint
- Endpoints
- Europe
- Fda
- Functional Gi Disorders
- Ibd
- Ibs
- In Licensing
- Inflammatory Bowel Disease
- Irritable Bowel Syndrome
- Ken Klein
- Kenneth B Klein
- Kenneth Klein
- London
- Migraine
- Other Company
- Pharmaceutical
- Pharmaceutical Due Diligence
- Primary Endpoint
- Seattle
- Seattle Tech
- Triptans
- Venture Capital
- Zolmitriptan
- Zomig
- Biotechnology and Pharmaceuticals
- CPMP
- EMEA
- FDA
- Functional GI Disorders
- IBD
- IBS
- In-licensing
- International Drug Development Consulting
- North America
- SeattleTech
- SeattleTechDoneDone